1.
Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–206.
PubMedCrossRef
2.
McDermott MM, Guralnik JM, Tian L, Ferrucci L, Liu K, Liao Y, Criqui MH. Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol. 2007;50:974–82.
PubMedPubMedCentralCrossRef
3.
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–40.
PubMedCrossRef
4.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.
PubMedCrossRef
5.
Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, Criqui MH. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32:328–33.
PubMedCrossRef
6.
Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, MM MD, Mendes DM, Nussmeier NA, Treat-Jacobson D, American Heart Association Council on Peripheral Vascular Disease, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Council on Epidemiology and Prevention. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1449–72.
PubMedCrossRef
7.
Creager MA, Libby P. Peripheral artery diseases. In: Mann DL, et al., editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. Philadelphia: Elsevier; 2015.
8.
Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly caucasian population: the Hoorn study. Diabetologia. 1995;38:86–96.
PubMedCrossRef
9.
Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJ. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract Diabetes Int. 1999;16:163–6.
CrossRef
10.
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–24.
PubMedCrossRef
11.
Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47:921–9.
PubMedCrossRef
12.
Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G, McDermott MM. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002;25:113–20.
PubMedCrossRef
13.
ADA. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–41.
CrossRef
14.
Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. 2004;116:236–40.
PubMedCrossRef
15.
Leibson CL, Ransom JE, Olson W, Zimmerman BR, O’Fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diabetes Care. 2004;27:2843–9.
PubMedCrossRef
16.
Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg. 2014;59:1291–9.
PubMedCrossRef
17.
Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vasc Med. 2016;21:445–52.
PubMedPubMedCentralCrossRef
18.
Oka RK, Sanders MG. The impact of type 2 diabetes and peripheral arterial disease on quality of life. J Vasc Nurs. 2005;23:61–66.; quiz 67-68.
PubMedCrossRef
19.
Gohil RA, Mockford KA, Mazari F, Khan J, Vanicek N, Chetter IC, Coughlin PA. Balance impairment, physical ability, and its link with disease severity in patients with intermittent claudication. Ann Vasc Surg. 2013;27:68–74.
PubMedCrossRef
20.
Suominen V, Salenius J, Sainio P, Reunanen A, Rantanen T. Peripheral arterial disease, diabetes and postural balance among elderly Finns: a population-based study. Aging Clin Exp Res. 2008;20:540–6.
21.
Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the medicare population. Vasc Med. 2008;13:209–15.
PubMedCrossRef
22.
ADA. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46.
CrossRef
23.
Kinlay S. Vascular biology overview. In: Slovut D, et al., editors. Comprehensive review in vascular and endovascular medicine. Minneapolis: Cardiotext; 2012. p. 3–15.
24.
Hiatt WR, Brass EP. Pathophysiology of peripheral artery disease, intermittent claudication, and critical limb ischemia. In: Creager MA, Beckman JA, Loscalzo J, editors. Vascular medicine: a companion to Braunwald’s heart disease. Philadelphia: Elseveir; 2013. p. 223–30.
CrossRef
25.
McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women’s health and aging study. Circulation. 2000;101:1007–12.
PubMedCrossRef
26.
Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645–58.
PubMedPubMedCentral
27.
Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1:65–71.
PubMedCrossRef
28.
McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599–606.
PubMedCrossRef
29.
Landry GJ. Functional outcome of critical limb ischemia. J Vasc Surg. 2007;45(Suppl A):A141–8.
PubMedCrossRef
30.
Engelhardt M, Boos J, Bruijnen H, Wohlgemuth W, Willy C, Tannheimer M, Wolfle K. Critical limb ischaemia: initial treatment and predictors of amputation-free survival. Eur J Vasc Endovasc Surg. 2012;43:55–61.
PubMedCrossRef
31.
Coats P, Wadsworth R. Marriage of resistance and conduit arteries breeds critical limb ischemia. Am J Physiol Heart Circ Physiol. 2005;288:H1044–50.
PubMedCrossRef
32.
Lowe GD. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine. Ann Periodontol. 1998;3:121–6.
PubMedCrossRef
33.
Spreen MI, Gremmels H, Teraa M, Sprengers RW, Verhaar MC, Statius van Eps RG, de Vries JP, Mali WP, van Overhagen H, PADI and JUVENTAS Study Groups. Diabetes is associated with decreased limb survival in patients with critical limb ischemia: pooled data from two randomized controlled trials. Diabetes Care. 2016;39:2058–64.
34.
Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ, German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120:2053–61.
PubMedCrossRef
35.
Gerhard-Herman M, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin J, Patel R, Regensteiner J, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. Circulation. 2017;135:e686-e725.
36.
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2011;58:2020–45.
PubMedCrossRef
37.
Gerhard-Herman M, Beckman JA, Creager MA. Vascular laboratory testing. In: Creager MA, Beckman JA, Loscalzo J, editors. Vascular medicine: a companion to Braunwald’s heart disease. Philadelphia: Elsevier; 2013. p. 148–65.
CrossRef
38.
Carter SA, Tate RB. The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene. J Vasc Surg. 2001;33:708–14.
PubMedCrossRef
39.
Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. CMAJ. 1996;155:1053–9.
PubMedPubMedCentral
40.
Girolami B, Bernardi E, Prins MH, Ten Cate JW, Hettiarachchi R, Prandoni P, Girolami A, Buller HR. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med. 1999;159:337–45.
PubMedCrossRef
41.
Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev CD005262, 2015.
42.
Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002;50:1939–46.
PubMedCrossRef
43.
Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation. 1998;98:678–86.
PubMedCrossRef
44.
Hiatt WR. The US experience with cilostazol in treating intermittent claudication. Atheroscler Suppl. 2005;6:21–31.
45.
Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd, Martin JD, Bortey EB, Forbes WP, Strandness DE Jr. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000;109:523–30.
PubMedCrossRef
46.
Rendell M, Cariski AT, Hittel N, Zhang P. Cilostazol treatment of claudication in diabetic patients. Curr Med Res Opin. 2002;18:479–87.
PubMedCrossRef
47.
Zhang J, Xiao Z, Chen L, Li L, Yang H, Luo B, Mai L, Yan L, Yang C. Cilostazol can increase skin oxygen supply assessed by transcutaneous oxygen pressure measurement in type 2 diabetes with lower limb ischemic disease: a randomized trial. J Wound Ostomy Continence Nurs. 2016;43:254-59.
48.
de Franciscis S, Gallelli L, Battaglia L, Molinari V, Montemurro R, Stillitano DM, Buffone G, Serra R. Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease. Int Wound J. 2015;12:250–3.
PubMedCrossRef
49.
O’Donnell ME, Badger SA, Sharif MA, Makar RR, Young IS, Lee B, Soong CV. The effects of cilostazol on peripheral neuropathy in diabetic patients with peripheral arterial disease. Angiology. 2008;59:695–704.
PubMedCrossRef
50.
Rosales RL, Santos MM, Mercado-Asis LB. Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND). Angiology. 2011;62:625–35.
PubMedCrossRef
51.
Parakramawansha R, Fisher M, McKay G. Naftidrofuryl. Pract Diabetes. 2014;31:129–30.
CrossRef
52.
Thukkani AK, Kinlay S. Endovascular intervention for peripheral artery disease. Circ Res. 2015;116:1599–613.
PubMedPubMedCentralCrossRef
53.
Singh S, Armstrong EJ, Sherif W, Alvandi B, Westin GG, Singh GD, Amsterdam EA, Laird JR. Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty. Vasc Med. 2014;19:307–14.
PubMedPubMedCentralCrossRef
54.
Malyar NM, Freisinger E, Meyborg M, Luders F, Gebauer K, Reinecke H, Lawall H. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. J Diabetes Complicat. 2016;30:1117–22.
55.
Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6:961–9.
PubMedPubMedCentralCrossRef
56.
Sun NF, Tian AL, Tian YL, Hu SY, Xu L. The interventional therapy for diabetic peripheral artery disease. BMC Surg. 2013;13:32.
PubMedPubMedCentralCrossRef
57.
Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33:e147–67.
PubMedPubMedCentralCrossRef
58.
Hiatt W, Nawaz D, Regensteiner J, Hossack K. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardpulm Rehabil. 1988;12:525–32.
CrossRef
59.
Cavalcante BR, Farah BQ, dos A Barbosa JP, Cucato GG, da Rocha Chehuen M, da Silva Santana F, Wolosker N, de Moraes Forjaz CL, Ritti-Dias RM. Are the barriers for physical activity practice equal for all peripheral artery disease patients? Arch Phys Med Rehabil. 2015;96:248–52.
PubMedCrossRef
60.
Borg G. Borg’s perceived exertion and pain scales. Champaign: Human Kinetics; 1998.
61.
Robertson RJ. Perceived exertion for practitioners: rating effort with the OMNI picture system. Champaign: Human Kinetics; 2004. p. 184.
62.
McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe M, Domanchuk K, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301:165–74.
PubMedPubMedCentralCrossRef
63.
Mays RJ, Hiatt WR, Casserly IP, Rogers RK, Main DS, Kohrt WM, Ho PM, Regensteiner JG. Community-based walking exercise for peripheral artery disease: an exploratory pilot study. Vasc Med. 2015;20:339–47.
PubMedPubMedCentralCrossRef
64.
Andrew GM, Oldridge NB, Parker JO, Cunningham DA, Rechnitzer PA, Jones NL, Buck C, Kavanagh T, Shephard RJ, Sutton JR. Reasons for dropout from exercise programs in post-coronary patients. Med Sci Sports Exerc. 1981;13:164–8.
PubMedCrossRef
65.
Sallis JF, Hovell MF, Hofstetter CR, Elder JP, Hackley M, Caspersen CJ, Powell KE. Distance between homes and exercise facilities related to frequency of exercise among San Diego residents. Public Health Rep. 1990;105:179–85.
66.
Raynor DA, Coleman KJ, Epstein LH. Effects of proximity on the choice to be physically active or sedentary. Res Q Exerc Sport. 1998;69:99–103.
PubMedCrossRef
67.
Regensteiner JG, Stewart KJ. Established and evolving medical therapies for claudication in patients with peripheral arterial disease. Nat Clin Pract Cardiovasc Med. 2006;3:604–10.
PubMedCrossRef
68.
Mouser MJ, Zlabek JA, Ford CL, Mathiason MA. Community trial of home-based exercise therapy for intermittent claudication. Vasc Med. 2009;14:103–7.
PubMedCrossRef
69.
Savage P, Ricci MA, Lynn M, Gardner A, Knight S, Brochu M, Ades P. Effects of home versus supervised exercise for patients with intermittent claudication. J Cardpulm Rehabil. 2001;21:152–7.
CrossRef
70.
Wullink M, Stoffers HE, Kuipers H. A primary care walking exercise program for patients with intermittent claudication. Med Sci Sports Exerc. 2001;33:1629–34.
PubMedCrossRef
71.
Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology. 1997;48:291–300.
PubMedCrossRef
72.
Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev CD005263, 2006.
73.
Hillsdon M, Thorogood M, White I, Foster C. Advising people to take more exercise is ineffective: a randomized controlled trial of physical activity promotion in primary care. Int J Epidemiol. 2002;31:808–15.
PubMedCrossRef
74.
Hageman D, Gommans LN, Scheltinga MR, Teijink JA. Effect of diabetes mellitus on walking distance parameters after supervised exercise therapy for intermittent claudication: a systematic review. Vasc Med. 2017;22:21–7.
PubMedCrossRef
75.
Lyu X, Li S, Peng S, Cai H, Liu G, Ran X. Intensive walking exercise for lower extremity peripheral arterial disease: a systematic review and meta-analysis. J Diabetes. 2016;8:363–77.
PubMedCrossRef
76.
Wang E, Hoff J, Loe H, Kaehler N, Helgerud J. Plantar flexion: an effective training for peripheral arterial disease. Eur J Appl Physiol. 2008;104:749–56.
PubMedCrossRef
77.
Mosti MP, Wang E, Wiggen ON, Helgerud J, Hoff J. Concurrent strength and endurance training improves physical capacity in patients with peripheral arterial disease. Scand J Med Sci Sports. 2011;21:e308–14.
PubMedCrossRef
78.
Collins EG, O’Connell S, McBurney C, Jelinek C, Butler J, Reda D, Gerber BS, Hurt C, Grabiner M. Comparison of walking with poles and traditional walking for peripheral arterial disease rehabilitation. J Cardiopulm Rehabil Prev. 2012;32:210–8.
PubMedPubMedCentralCrossRef
79.
Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009;14:203–13.
PubMedCrossRef
80.
Walker RD, Nawaz S, Wilkinson CH, Saxton JM, Pockley AG, Wood RF. Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication. J Vasc Surg. 2000;31:662–9.
PubMedCrossRef
81.
Ritti-Dias RM, Wolosker N, de Moraes Forjaz CL, Carvalho CR, Cucato GG, Leao PP, de Fatima Nunes Marucci M. Strength training increases walking tolerance in intermittent claudication patients: randomized trial. J Vasc Surg. 2010;51:89–95.
PubMedCrossRef
82.
Mays RJ, Casserly IP, Regensteiner JG. Peripheral artery disease. In: Ehrman JK, et al., editors. Clinical exercise physiology. Champaign: Human Kinetics; 2013. p. 277–95.
83.
Tsantilas D, Hatzitolios AI, Tziomalos K, Papadimitriou DK. Buflomedil: potential new indications for an old agent. Int Angiol. 2009;28:170–4.
PubMed
84.
Gornik HL, Creager MA. Medical treatment of peripheral artery disease. In: Creager MA, Beckman JA, Loscalzo J, editors. Vascular medicine: a companion to Braunwald’s heart disease. Philadelphia: Elsevier; 2013. p. 242–58.
CrossRef
85.
Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular clinical trialists. Circulation. 1995;92:614–21.
PubMedCrossRef
86.
Hiatt WR, Rogers RK, Brass EP. The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation. 2014;130:69–78.
PubMedCrossRef
87.
Gardner AW, Skinner JS, Vaughan NR, Bryant CX, Smith LK. Comparison of three progressive exercise protocols in peripheral vascular occlusive disease. Angiology. 1992;43:661–71.
PubMedCrossRef
88.
Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991;23:402–8.
PubMedCrossRef
89.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.
CrossRef
90.
McDermott MM. Functional impairment in peripheral artery disease and how to improve it in 2013. Curr Cardiol Rep. 2013;15:347.
PubMedPubMedCentralCrossRef
91.
McDermott MM, Guralnik JM, Criqui MH, Liu K, Kibbe MR, Ferrucci L. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation. 2014;130:61–8.
PubMedPubMedCentralCrossRef
92.
Le Faucheur A, Abraham P, Jaquinandi V, Bouye P, Saumet JL, Noury-Desvaux B. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system. Circulation. 2008;117:897–904.
PubMedCrossRef
93.
McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian L, Liao Y, Criqui MH. Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc. 2010;58:1256–62.
PubMedPubMedCentralCrossRef
94.
da Cunha-Filho IT, Pereira DA, de Carvalho AM, Campedeli L, Soares M, de Sousa Freitas J. The reliability of walking tests in people with claudication. Am J Phys Med Rehabil. 2007;86:574–82.
PubMedCrossRef
95.
McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H, Zhao L, Liao Y, Rejeski WJ. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310:57–65.
PubMedCrossRef
96.
Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2014;7:CD000990.
97.
Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis. 2011;218:1–12.
PubMedCrossRef
98.
Gardner AW, Parker DE, Montgomery PS, Blevins SM. Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication. J Vasc Surg. 2014;59:1036–43.
PubMedCrossRef
99.
Collins TC, Lunos S, Carlson T, Henderson K, Lightbourne M, Nelson B, Hodges JS. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care. 2011;34:2174–9.
PubMedPubMedCentralCrossRef
100.
van Pul KM, Kruidenier LM, Nicolai SP, de Bie RA, Nieman FH, Prins MH, Teijink JA. Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus. Ann Vasc Surg. 2012;26:957–63.
PubMedCrossRef
101.
Bauer TA, Reusch JE, Levi M, Regensteiner JG. Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Diabetes Care. 2007;30:2880–5.
PubMedCrossRef
102.
Mohler ER 3rd, Lech G, Supple GE, Wang H, Chance B. Impaired exercise-induced blood volume in type 2 diabetes with or without peripheral arterial disease measured by continuous-wave near-infrared spectroscopy. Diabetes Care. 2006;29:1856–9.
PubMedCrossRef
103.
Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015;45:231–44.
PubMedCrossRef
104.
Allen JD, Stabler T, Kenjale AA, Ham KL, Robbins JL, Duscha BD, Kraus WE, Annex BH. Diabetes status differentiates endothelial function and plasma nitrite response to exercise stress in peripheral arterial disease following supervised training. J Diabetes Complicat. 2014;28:219–25.
PubMedCrossRef
105.
Collins TC, Twumasi-Ankrah P. A walking intervention to reduce inflammation in patients with diabetes and peripheral arterial/artery disease: a pilot study. SAGE Open Med. 2013;1:2050312113505559.
PubMedPubMedCentralCrossRef
106.
Mays RJ, Casserly IP, Kohrt WM, Ho PM, Hiatt WR, Nehler MR, Regensteiner JG. Assessment of functional status and quality of life in claudication. J Vasc Surg. 2011;53:1410–21.
PubMedPubMedCentralCrossRef
107.
Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionniare in patients with peripheral artery disease. J Vasc Med Biol. 1990;2:142–52.
108.
Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the vascular quality of life questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001;33:679–87.
PubMedCrossRef
109.
Spertus J, Jones P, Poler S, Rocha-Singh K. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J. 2004;147:301–8.
PubMedCrossRef
110.
Treat-Jacobson D, Lindquist RA, Witt DR, Kirk LN, Schorr EN, Bronas UG, Davey CS, Regensteiner JG. The PADQoL: development and validation of a PAD-specific quality of life questionnaire. Vasc Med. 2012;17:405–15.
PubMedCrossRef
111.
Menard JR, Smith HE, Riebe D, Braun CM, Blissmer B, Patterson RB. Long-term results of peripheral arterial disease rehabilitation. J Vasc Surg. 2004;39:1186–92.
PubMedCrossRef
112.
Coffman JD. Intermittent claudication – be conservative. N Engl J Med. 1991;325:577–8.
PubMedCrossRef
113.
Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med. 1990;113:135–46.
PubMedCrossRef
114.
Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg. 2011;41:110–6.
PubMedCrossRef
115.
Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444–52.
116.
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the accord, advance, and va diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009;53:298–304.
PubMedCrossRef
117.
Hinchliffe RJ, Brownrigg JR, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers J, Shearman CP, Zierler RE, Schaper NC, International Working Group on the Diabetic Foot. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):37–44.
118.
Thapa R, Sharma S, Jeevanantham V, Hu C, Myers T, Vacek JL, Dawn B, Gupta K. Disparities in lipid control and statin drug use among diabetics with noncoronary atherosclerotic vascular disease vs those with coronary artery disease. J Clin Lipidol. 2015;9:241–6.
PubMedCrossRef
119.
Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, Fisher EB, Hanson L, Kent D, Kolb L, McLaughlin S, Orzeck E, Piette JD, Rhinehart AS, Rothman R, Sklaroff S, Tomky D, Youssef G, Standards Revision Task F. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(Suppl 1):S144–53.
PubMedCrossRef
120.
Olin JW, Allie DE, Belkin M, Bonow RO, Casey DE Jr, Creager MA, Gerber TC, Hirsch AT, Jaff MR, Kaufman JA, Lewis CA, Martin ET, Martin LG, Sheehan P, Stewart KJ, Treat-Jacobson D, White CJ, Zheng ZJ, Masoudi FA, Bonow RO, DeLong E, Erwin JP 3rd, Goff DC Jr, Grady K, Green LA, Heidenreich PA, Jenkins KJ, Loth AR, Peterson ED, Shahian DM, American College of Cardiology Foundation, American Heart Association, American College of Radiology, Society for Cardiac Angiography and Interventions, Society for Interventional Radiology, Society for Vascular Medicine, Society for Vascular Nursing, Society for Vascular Surgery. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (writing committee to develop clinical performance measures for peripheral artery disease). J Am Coll Cardiol. 2010;56:2147–81.
PubMedCrossRef
121.
Mitchell RG, Duscha BD, Robbins JL, Redfern SI, Chung J, Bensimhon DR, Kraus WE, Hiatt WR, Regensteiner JG, Annex BH. Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral artery disease. Vasc Med. 2007;12:285–90.
122.
Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011;123:491–8.
PubMedPubMedCentralCrossRef